Low dose cyclosporine strategy for cadaver kidney transplantation

John Barry, J. R. Serra, T. R. Hefty, Douglas Norman, W. M. Bennett

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The use of cyclosporine after cadaver kidney transplantation has improved graft survival at one and two years in most large controlled studies. Early acute and late chronic nephrotoxicity have emerged as the major drawbacks in the use of this new immunosuppressant. Because of the authors concerns about nephrotoxicity they began to use the drug selectively in their cadaver kidney transplant program early in 1984. They are reporting their experience with two cyclosporine protocols in 38 cadaver kidney transplants, one of which is a low-dose strategy they hope will allow optimal use of the drug.

Original languageEnglish (US)
Pages (from-to)125-127
Number of pages3
JournalTransplantation Proceedings
Volume18
Issue number2 SUPPL. 1
StatePublished - 1986

Fingerprint

Cadaver
Kidney Transplantation
Cyclosporine
Transplants
Kidney
Graft Survival
Immunosuppressive Agents
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Barry, J., Serra, J. R., Hefty, T. R., Norman, D., & Bennett, W. M. (1986). Low dose cyclosporine strategy for cadaver kidney transplantation. Transplantation Proceedings, 18(2 SUPPL. 1), 125-127.

Low dose cyclosporine strategy for cadaver kidney transplantation. / Barry, John; Serra, J. R.; Hefty, T. R.; Norman, Douglas; Bennett, W. M.

In: Transplantation Proceedings, Vol. 18, No. 2 SUPPL. 1, 1986, p. 125-127.

Research output: Contribution to journalArticle

Barry, J, Serra, JR, Hefty, TR, Norman, D & Bennett, WM 1986, 'Low dose cyclosporine strategy for cadaver kidney transplantation', Transplantation Proceedings, vol. 18, no. 2 SUPPL. 1, pp. 125-127.
Barry, John ; Serra, J. R. ; Hefty, T. R. ; Norman, Douglas ; Bennett, W. M. / Low dose cyclosporine strategy for cadaver kidney transplantation. In: Transplantation Proceedings. 1986 ; Vol. 18, No. 2 SUPPL. 1. pp. 125-127.
@article{04b7725cf62347e0be376c9cdc8de994,
title = "Low dose cyclosporine strategy for cadaver kidney transplantation",
abstract = "The use of cyclosporine after cadaver kidney transplantation has improved graft survival at one and two years in most large controlled studies. Early acute and late chronic nephrotoxicity have emerged as the major drawbacks in the use of this new immunosuppressant. Because of the authors concerns about nephrotoxicity they began to use the drug selectively in their cadaver kidney transplant program early in 1984. They are reporting their experience with two cyclosporine protocols in 38 cadaver kidney transplants, one of which is a low-dose strategy they hope will allow optimal use of the drug.",
author = "John Barry and Serra, {J. R.} and Hefty, {T. R.} and Douglas Norman and Bennett, {W. M.}",
year = "1986",
language = "English (US)",
volume = "18",
pages = "125--127",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "2 SUPPL. 1",

}

TY - JOUR

T1 - Low dose cyclosporine strategy for cadaver kidney transplantation

AU - Barry, John

AU - Serra, J. R.

AU - Hefty, T. R.

AU - Norman, Douglas

AU - Bennett, W. M.

PY - 1986

Y1 - 1986

N2 - The use of cyclosporine after cadaver kidney transplantation has improved graft survival at one and two years in most large controlled studies. Early acute and late chronic nephrotoxicity have emerged as the major drawbacks in the use of this new immunosuppressant. Because of the authors concerns about nephrotoxicity they began to use the drug selectively in their cadaver kidney transplant program early in 1984. They are reporting their experience with two cyclosporine protocols in 38 cadaver kidney transplants, one of which is a low-dose strategy they hope will allow optimal use of the drug.

AB - The use of cyclosporine after cadaver kidney transplantation has improved graft survival at one and two years in most large controlled studies. Early acute and late chronic nephrotoxicity have emerged as the major drawbacks in the use of this new immunosuppressant. Because of the authors concerns about nephrotoxicity they began to use the drug selectively in their cadaver kidney transplant program early in 1984. They are reporting their experience with two cyclosporine protocols in 38 cadaver kidney transplants, one of which is a low-dose strategy they hope will allow optimal use of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0022886591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022886591&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 125

EP - 127

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 2 SUPPL. 1

ER -